Search

everythinglearnresearchcommunity

for

Search:↓

Educating dermatologists and screening for related conditions are crucial for treating folliculitis decalvans effectively.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Managing inflammation and using vitamins can improve PRP therapy for better hair growth.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Different treatments are effective for hair loss conditions, but results vary by individual factors.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Winter-onset alopecia areata patients are more likely to regrow hair within a year compared to spring-onset patients.

Haloperidol effectively treated hemiballismus, but spontaneous improvement wasn't ruled out; rapid weight loss can cause hair loss with good regrowth chances.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Finasteride and dutasteride might lower melanoma risk.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.